Dr. Timothy E. Ryan, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Maryland School of Medicine (2017)
- Years since graduation
- 9
- In the NPI registry since
- 2017
- Medicare patients seen, 2024
- 435
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Medical school: University of Maryland School of Medicine
- 2017Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
NC license 2022-00173 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Wakemed, Raleigh Campus Raleigh, NC
- Wakemed, Cary Hospital Cary, NC
Medical groups
- Wakemed (70 clinicians)
- Raleigh Neurology Associates, P. A. (52 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 435
- Services billed
- 16,166
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, natalizumab, 1 mg | 3,001 | 11 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 190 | 121 |
| Established patient office or other outpatient visit, 30-39 minutes | 103 | 72 |
| Measurement of brain wave activity (eeg), awake and drowsy | 91 | 91 |
| New patient office or other outpatient visit, 60-74 minutes | 83 | 83 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 78 | 40 |
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 41 | 27 |
| Nerve conduction, 9-10 studies | 38 | 38 |
| Nerve conduction, 7-8 studies | 31 | 31 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 29 | 29 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 22 companies reported 134 payments worth $58,416 in total to this clinician.
| Janssen Biotech, Inc. | $20,949 |
|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $18,162 |
| Neurelis, Inc. | $17,694 |
| Livanova USA, Inc. | $702 |
| UCB, Inc. | $223 |
| AbbVie Inc. | $91.26 |
| Amgen Inc. | $86.47 |
| Acadia Pharmaceuticals Inc | $74.14 |
| Compensation for services other than consulting (speaking, faculty) | $47,990 |
|---|---|
| Travel and Lodging | $7,753 |
| Food and Beverage | $2,626 |
| Education | $46.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) HYQVIA · IMMUNOLOGY | $4,474 |
| Janssen Biotech, Inc. Jul 12, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,885 |
| Janssen Biotech, Inc. Dec 6, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,885 |
| Janssen Biotech, Inc. Aug 23, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,885 |
| Takeda Pharmaceuticals U.S.A., Inc. Aug 27, 2025 | Compensation for services other than consulting (speaking, faculty) HYQVIA · IMMUNOLOGY | $3,696 |
| Takeda Pharmaceuticals U.S.A., Inc. Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) HYQVIA · IMMUNOLOGY | $3,307 |
| Takeda Pharmaceuticals U.S.A., Inc. Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) HYQVIA · IMMUNOLOGY | $3,307 |
| Neurelis, Inc. Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $2,862 |
| Neurelis, Inc. Jan 30, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $2,862 |
| Neurelis, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $2,862 |
All 58 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Dec 20, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,110 |
| Janssen Biotech, Inc. Dec 18, 2025 | Education in-kind | $46.99 |
| Janssen Biotech, Inc. Dec 6, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,885 |
| Neurelis, Inc. Dec 5, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $2,862 |
| Janssen Biotech, Inc. Dec 4, 2025 | Travel and Lodging travel to WILLIAMSVILLE, NY · in-kind | $707 |
| Janssen Biotech, Inc. Dec 4, 2025 | Travel and Lodging travel to WILLIAMSVILLE, NY · in-kind | $693 |
| Janssen Biotech, Inc. Dec 4, 2025 | Travel and Lodging travel to WILLIAMSVILLE, NY · in-kind | $202 |
| Neurelis, Inc. Nov 20, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to CRAB ORCHARD, WV | $363 |
| Neurelis, Inc. Nov 20, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to CRAB ORCHARD, WV | $21.56 |
| Janssen Biotech, Inc. Nov 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,498 |
| Janssen Biotech, Inc. Nov 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,498 |
| Janssen Biotech, Inc. Nov 12, 2025 | Travel and Lodging travel to CARY, NC | $16.80 |
| Neurelis, Inc. Nov 6, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to CRAB ORCHARD, WV · in-kind | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. Aug 27, 2025 | Compensation for services other than consulting (speaking, faculty) HYQVIA · IMMUNOLOGY | $3,696 |
| Janssen Biotech, Inc. Aug 26, 2025 | Travel and Lodging travel to LEXINGTON, NC | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. Aug 25, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to WASHINGTON, DC · in-kind | $28.00 |
| Takeda Pharmaceuticals U.S.A., Inc. Aug 25, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to WASHINGTON, DC · in-kind | $8.00 |
| Janssen Biotech, Inc. Aug 23, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,885 |
| Neurelis, Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $898 |
| Takeda Pharmaceuticals U.S.A., Inc. Aug 1, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to WASHINGTON, DC · in-kind | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. Aug 1, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to WASHINGTON, DC · in-kind | $336 |
| Janssen Biotech, Inc. Jul 12, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,885 |
| Janssen Biotech, Inc. Jul 12, 2025 | Travel and Lodging travel to CHICAGO, IL | $64.00 |
| Janssen Biotech, Inc. Jun 27, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $272 |
| Janssen Biotech, Inc. Jun 27, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $227 |
| Janssen Biotech, Inc. Jun 27, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $217 |
| Takeda Pharmaceuticals U.S.A., Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) HYQVIA · IMMUNOLOGY | $4,474 |
| Takeda Pharmaceuticals U.S.A., Inc. May 12, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to LOUISVILLE, KY · in-kind | $64.00 |
| Takeda Pharmaceuticals U.S.A., Inc. May 12, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to LOUISVILLE, KY · in-kind | $25.00 |
| Takeda Pharmaceuticals U.S.A., Inc. May 12, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to LOUISVILLE, KY · in-kind | $20.19 |
| Takeda Pharmaceuticals U.S.A., Inc. May 12, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to LOUISVILLE, KY · in-kind | $19.85 |
| Takeda Pharmaceuticals U.S.A., Inc. Apr 24, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to LOUISVILLE, KY · in-kind | $547 |
| Takeda Pharmaceuticals U.S.A., Inc. Apr 24, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to LOUISVILLE, KY · in-kind | $388 |
| Takeda Pharmaceuticals U.S.A., Inc. Apr 24, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to LOUISVILLE, KY · in-kind | $229 |
| Takeda Pharmaceuticals U.S.A., Inc. Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) HYQVIA · IMMUNOLOGY | $3,307 |
| Takeda Pharmaceuticals U.S.A., Inc. Apr 11, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to VIRGINIA BEACH, VA · in-kind | $285 |
| Livanova USA, Inc. Mar 31, 2025 | Travel and Lodging VNS Therapy · Neurology · travel to Washington, DC | $104 |
| Livanova USA, Inc. Mar 28, 2025 | Travel and Lodging VNS Therapy · Neurology · travel to Washington, DC · in-kind | $363 |
| Takeda Pharmaceuticals U.S.A., Inc. Mar 26, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to VIRGINIA BEACH, VA · in-kind | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. Mar 26, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to VIRGINIA BEACH, VA · in-kind | $50.00 |
| Takeda Pharmaceuticals U.S.A., Inc. Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) HYQVIA · IMMUNOLOGY | $3,307 |
| Takeda Pharmaceuticals U.S.A., Inc. Mar 20, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to RICHMOND, VA · in-kind | $214 |
| Neurelis, Inc. Mar 20, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to GREENVILLE, NC | $121 |
| Neurelis, Inc. Mar 20, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to GREENVILLE, NC | $2.35 |
| Neurelis, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $2,862 |
| Neurelis, Inc. Feb 28, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to GREENVILLE, NC · in-kind | $236 |
| Neurelis, Inc. Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $1,193 |
| Takeda Pharmaceuticals U.S.A., Inc. Feb 25, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to RICHMOND, VA · in-kind | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. Feb 25, 2025 | Travel and Lodging HYQVIA · IMMUNOLOGY · travel to RICHMOND, VA · in-kind | $50.00 |
| Neurelis, Inc. Feb 13, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $1,908 |
| Neurelis, Inc. Feb 6, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to RALEIGH, NC | $13.44 |
| Neurelis, Inc. Jan 30, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $2,862 |
| Neurelis, Inc. Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) VALTOCO · EPILEPSY | $2,862 |
| Neurelis, Inc. Jan 23, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to HUNTINGTON, WV | $189 |
| Neurelis, Inc. Jan 23, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to WILMINGTON, NC | $188 |
| Neurelis, Inc. Jan 23, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to HUNTINGTON, WV | $173 |
| Neurelis, Inc. Jan 23, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to HUNTINGTON, WV | $19.23 |
| Neurelis, Inc. Jan 8, 2025 | Travel and Lodging VALTOCO · EPILEPSY · travel to HUNTINGTON, WV · in-kind | $259 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $37,798 in research payments for these studies, mostly to the institutions running them.
- A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset…
Jazz Pharmaceuticals Inc. - A Phase 3 Single Arm Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (TAK-881) for the Treatment of Chronic Inflamm…
Takeda Pharmaceuticals U.S.A., Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.